← United States · Coverage record
US · SEC FORM 4
Aditxt, Inc.
ADTX · OTC · CIK 0001726711 · Healthcare · Biotechnology
INSIDER SIGNAL
2 buyers · 10 purchase transaction lines · $356.8K gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
- ⚠ Purchase activity is becoming less recent
- ⚠ Buying conviction is reduced by concurrent selling
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth & concentration
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 34.5
- 34.4
- 34.4
- 34.3
- 34.2
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -55.7%
- 3M
- -22.5%
- 6M
- -100.0%
- 12M
- -100.0%
Volatility & liquidity
- Volatility
- 323.4%
- Beta
- —
- Avg daily value
- USD 83,010
Valuation
- Market cap
- USD 3.1M
- P/E
- 0.0×
Fundamentals
- Profit margin
- 0.0%
- ROE
- -768.3%
- Industry
- Biotechnology
Market data
Price data up to: 2026-10-05 · Price source: OpenBB/yfinance · From SEC filings: ROE · Fiscal year ended: 2025-12-31 · From Yahoo Finance: Market cap, P/E, Profit margin · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 898,241
- Previous report
- 897,756
- Avg daily volume
- 26,268,157
- Days to cover
- ≤ 1.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 7,340,178 | USD 0.01 | USD 73,402 | SEC filing ↗ |
| 2026-06-15 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 2,114,344 | USD 0.01 | USD 21,143 | SEC filing ↗ |
| 2026-06-12 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 4,252,767 | USD 0.02 | USD 85,055 | SEC filing ↗ |
| 2026-06-11 | BANK OF AMERICA CORP /DE/; BANK OF AMERICA NA; BOFA SECURITIES, INC. | Purchase (P) | COMMON STOCK | 5 | USD 0.01 | USD 0 | SEC filing ↗ |
| 2026-06-10 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 725,330 | USD 0.02 | USD 14,507 | SEC filing ↗ |
| 2026-06-08 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 1,423,493 | USD 0.05 | USD 71,175 | SEC filing ↗ |
| 2026-06-04 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 843,622 | USD 0.08 | USD 67,490 | SEC filing ↗ |
| 2026-04-21 | HRT FINANCIAL LP | Purchase (P) | Class A Shares | 72,912 | USD 0.33 | USD 24,061 | SEC filing ↗ |
| 2024-10-15 | HRT FINANCIAL LP | Purchase (P) | Class A Shares | 15,636 | USD 1.50 | USD 23,454 | SEC filing ↗ |
| 2022-07-19 | Albanna Amro A. | Purchase (P) | Series B Preferred Stock | 1 | USD 20,000.00 | USD 20,000 | SEC filing ↗ |
| 2021-06-01 | Shabahang Shahrokh | Purchase (P) | Common Stock | 490 | USD 2.93 | USD 1,436 | SEC filing ↗ |
| 2021-06-01 | Runge Jeffrey W. | Purchase (P) | Common Stock | 7,300 | USD 2.94 | USD 21,426 | SEC filing ↗ |
| 2021-06-01 | Albanna Rowena | Purchase (P) | Common Stock | 2,400 | USD 2.93 | USD 7,024 | SEC filing ↗ |
| 2021-06-01 | Albanna Amro A. | Purchase (P) | Common Stock | 2,400 | USD 2.93 | USD 7,024 | SEC filing ↗ |
| 2021-05-27 | Shabahang Shahrokh | Purchase (P) | Common Stock | 185 | USD 2.70 | USD 500 | SEC filing ↗ |
Form 4 evidence
24 transaction lines in the latest 365-day window; 60 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-23 | Takeover Time 2026 LLC | Sale (S) | Common Stock | 3,420,439 | USD 0.02 | USD 68,409 | SEC filing ↗ |
| 2026-06-22 | HRT FINANCIAL LP | Sale (S) | Common Stock | 5,120,480 | USD 0.02 | USD 102,410 | SEC filing ↗ |
| 2026-06-18 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 7,340,178 | USD 0.01 | USD 73,402 | SEC filing ↗ |
Show recent Form 4 evidence (22 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-23 | Takeover Time 2026 LLC | Sale (S) | Common Stock | 3,420,439 | USD 0.02 | USD 68,409 | SEC filing ↗ |
| 2026-06-22 | HRT FINANCIAL LP | Sale (S) | Common Stock | 5,120,480 | USD 0.02 | USD 102,410 | SEC filing ↗ |
| 2026-06-18 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 7,340,178 | USD 0.01 | USD 73,402 | SEC filing ↗ |
| 2026-06-17 | DRW Securities, LLC | Sale (S) | Common Stock | 126,772 | USD 0.01 | USD 1,268 | SEC filing ↗ |
| 2026-06-16 | HRT FINANCIAL LP | Sale (S) | Class A Shares | 3,132,480 | USD 0.01 | USD 31,325 | SEC filing ↗ |
| 2026-06-15 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 2,114,344 | USD 0.01 | USD 21,143 | SEC filing ↗ |
| 2026-06-12 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 4,252,767 | USD 0.02 | USD 85,055 | SEC filing ↗ |
| 2026-06-11 | BANK OF AMERICA CORP /DE/; BANK OF AMERICA NA; BOFA SECURITIES, INC. | Sale (S) | COMMON STOCK | 15 | USD 0.01 | USD 0 | SEC filing ↗ |
| 2026-06-11 | BANK OF AMERICA CORP /DE/; BANK OF AMERICA NA; BOFA SECURITIES, INC. | Purchase (P) | COMMON STOCK | 5 | USD 0.01 | USD 0 | SEC filing ↗ |
| 2026-06-11 | HRT FINANCIAL LP | Sale (S) | Common Stock | 2,833,463 | USD 0.01 | USD 28,335 | SEC filing ↗ |
| 2026-06-10 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 725,330 | USD 0.02 | USD 14,507 | SEC filing ↗ |
| 2026-06-09 | HRT FINANCIAL LP | Sale (S) | Common Stock | 878,659 | USD 0.03 | USD 26,360 | SEC filing ↗ |
| 2026-06-09 | Gong Sandie; Xu Devon Xin | Sale (S) | Common Stock | 100,000 | USD 0.07 | USD 7,000 | SEC filing ↗ |
| 2026-06-08 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 1,423,493 | USD 0.05 | USD 71,175 | SEC filing ↗ |
| 2026-06-05 | HRT FINANCIAL LP | Sale (S) | Common Stock | 735,462 | USD 0.06 | USD 44,128 | SEC filing ↗ |
| 2026-06-04 | HRT FINANCIAL LP | Purchase (P) | Common Stock | 843,622 | USD 0.08 | USD 67,490 | SEC filing ↗ |
| 2026-04-24 | HRT FINANCIAL LP | Sale (S) | Class A Shares | 29,404 | USD 0.28 | USD 8,233 | SEC filing ↗ |
| 2026-04-23 | HRT FINANCIAL LP | Sale (S) | Class A Shares | 3,811 | USD 0.29 | USD 1,105 | SEC filing ↗ |
| 2026-04-22 | HRT FINANCIAL LP | Sale (S) | Class A Shares | 11,982 | USD 0.30 | USD 3,595 | SEC filing ↗ |
| 2026-04-21 | HRT FINANCIAL LP | Purchase (P) | Class A Shares | 72,912 | USD 0.33 | USD 24,061 | SEC filing ↗ |
| 2025-12-17 | Brady Brian Michael | Sale (S) | Common Stock | 1 | USD 1.75 | USD 2 | SEC filing ↗ |
| 2025-11-25 | Pankovcin Corinne | Sale (S) | Common Stock | 1 | USD 3.20 | USD 3 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | ADTX |
| CIK | 0001726711 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | OTC |
Data coverage
| Local Form 4 history | 60 transaction lines from 2020-07-02 to 2026-06-23 31 P purchase lines · 16 S sale lines · 13 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.